Virtual research organisation (VRO) ObvioHealth has entered a partnership with Chemist Warehouse to increase the efficiency of clinical trials in Australia. 

Under the collaboration, sponsors will get access to a wide-ranging pool of trial subjects by providing trial awareness to customers of Chemist Warehouse in the region. 

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

For promoting trials managed by ObvioHealth, Chemist Warehouse will offer focused, multichannel communication, comprising in-store and online touchpoints, to its customers. 

This comprises educating people about trials using a variety of media assets of Chemist Warehouse such as a wellness magazine, TV show, and editorial inserts in newspapers.

Under the deal, ObvioHealth has the option to use Instant Consult, the telehealth services of Chemist Warehouse, for studies that need the evaluation of clinicians. This approach will reduce the burden on participants by removing the requirement to travel to in-clinic appointments. 

ObvioHealth CEO Ivan Jarry said: “As trial sponsors increasingly look to Australia to conduct their research, we’re excited to offer a solution to overcome their biggest roadblock – finding and enrolling the right patients. 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“Two of the biggest recruitment hurdles are awareness and convenience, and this partnership tackles both. 

“The ability to communicate trial opportunities to an audience in a place where they are likely to be receptive, coupled with telehealth services to reduce participant burden, makes sense all around.”

In February this year, ObvioHealth partnered with Sterling IRB to expedite decentralised clinical trial access and adoption.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact